English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

    •
    Article
    World of Medicine and Biology / №4(62), 2017 / EPIGENETIC AND GENETIC ASPECTS OF RETT SYNDROME, ASSOCIATED WITH EPIMUTATION C → mC IN THE TRANSGENERATIONAL INHERITANCE
    Kovanova E.N., Bihunyak Т.V, Bihuniak K.O., Kulitska M.I.

    EPIGENETIC AND GENETIC ASPECTS OF RETT SYNDROME, ASSOCIATED WITH EPIMUTATION C → mC IN THE TRANSGENERATIONAL INHERITANCE

    About the author: Kovanova E.N., Bihunyak Т.V, Bihuniak K.O., Kulitska M.I.
    Heading BIOLOGY
    Type of article Scentific article
    Annotation The C→mC epimutation associated with the formation of methylcytosine in CpG islands occurs under the influence of environmental factors during the gametogenesis in the generation F0 of the boy-grandfather. Epimutation and the replacement of CG on АТ promote the production of defective MeCP2 protein that can deregulate gene expression in the postnatal development of the child's brain. Expression of the phenotype of Rett syndrome in transgenerational inheritance can be observed in the different generations grandson boy due to homozygosity of homologous loci of q28 X and Y chromosomes. As a result of transgenic inheritance in boys and girls of different generations there is a uniallelic and biallelic uniparent dysomia of mat and pat origin.
    Tags Rett syndrom, pat, mat origin, transgenerational inheritance, epimutation, uniparent dysomia
    Bibliography
    • Amir RE, Van den Yuser IB, Wan M, Tran CO, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2 encoding methyl-CpG- binding protein2, Nat. Genet. 1999; 23, 2:185-188.
    • Amir RE, Zoghbi HY. Rett Syndrome: methyl-CpG-binding protein 2 mutation and phenotype-genotype correlations. Am.J. Med.Genet. 2000; 97,2:147-152.
    • Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive process, Brain Res.Dev. 2003; 42, 33: 33-84.
    • Budgeb SS, Dorssey HC, Steine RD. Clinical profile of a male with Rett syndrome. Brain and Dev. 2005; 27: 569-571.
    • Charytonov VI, Kashin AI. Rett syndrome in a boy: the presentation of a case. Bulletin of the Association of Psychyatrits of Ukraine. 2012;1: 1-4.
    • Charytonov VI. Rett Syndrom`s diagnostic in a patient of male sex, NEURONEWS. 2013; 2 (47): 1-4.
    • Christodoulou J, Ho G. MeCP2 Related Disorders, 2012, pp 1-29. In Pagon RA, Adam MP, Ardinger HH., Wallace SE, Amemiya A, Bean LJH, Biard TD, Fong CT, Mefford HC, Smith RJH, Stephens K, Gene Reviews. [Internet] Seattle (WA): University of Washington, Seattle Gene Reviers. 1993; 2016; 2012.
    • Delcuve GP, Rastergam M, Davia JR. Epigenetic Diseases. J. Cell.Physiol. 2009; 2: 243-250.
    • Gvozdev VF. Regulation of gene activity due to chemical modification (methylation) of DNA. Sorosovsky Educational Journal. 1999; 10: 11-17.
    • Giard M, Couvert P, Carrie A, Tardieu M, Chelly J, Beldjord C, Bienvenu T. Parental origin of de novo MECP2 mutations in Rett syndrome, Europ. Hum. Genet. 2001; l.9, 3: 231-236.
    • Grechanina JuB, Grechanina EJ. Epigenetic diseases. Rett syndrome. Clinical genetics. 2011; 1,2: 35-48.
    • Guerrini R, Parrini R. Epilepsy in Rett syndrome, and CDKL5- and FOXG1- Gene-related encephalopathies. Epilepsia. 2012; 12: 2067-2078.
    • Harberg B, Aicardi J, Dias K, Ramos O A. progressive syndrome of autism, dementia, ataxia, and loss purpuseful hand use in girls Rett`s syndrome: report of 35 causes, Annals of neurology.1983; 14, 4: 471-479.
    • Meloni I, Brutini M, Longo I, Man F, Rizzolio F, D`Adamo P, Denvnendt K, Fryns J-P, Toniolo D, Renieri A A. Mutation in the Rett Syndrome Gene, MECP2, Causes X-Linked Mental Retardation and Progressive Spasticity in Males. Am.J.Genet. 2000; 67.4: 982-985.
    • Moog U, Smeets EEJ, Roosendaal KEP, Schoenmakers S, Harberg J. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Europ.J. Pediatric Neurology. 2003; l.7, 1: 5-12.
    • Phillipart M. The Rett syndrome in male, Brain Dev. 1990; 12, 1: 33-36.
    • Rett A. On a unusual brain atrophy syndrome in hyperammanemia in childhood, Wien. Med. Wochen. 1966; 116, 37: 723-726.
    • Rasanzeva LZ, Ulas WU. Childre Rett Syndrome. J. Treatments doctors. 1998; 1: 1-9.
    • Renieri A, Meloni I, Longo I, Ariani E, Мari F, Pesscucci C, Cambi F. Rett Syndrome: the complex nature of a monogenic disease. J. Mol. Med.(Berlin). 2003; 81, 6: 346-354.
    • Shahbazlan MD, Young JI, Yuva-Paylor LA, Spencer CM, Antalffai BA, Noebels JL, Armstrong DL, Paylor R, Zoghbi HY. Mice with Truncated MeCP2 Recapitulated Many Rett Syndrome Feature and Display Hyperacetylation of Histone H3. . Brain Phys. 2002; 2: 243-254.
    • Villard L, Krebe A,Cardoso C, Chelly J, Tardieu U, Fontes M. Two affected boys in a Rett syndrome family. Neurology. 2000; 55, 8: 1188-1193.
    • Van den Yeyer IB, Zoghbi HY. Mutations in the gene encoding methyl-CpG- binding protein2 cause Rett syndrome, Brain. Dev. 2001; 1: 147-151.
    • Trappe R, Laccone F, Cobilanschi J, Meins M., Huppke P, Hanefeld F, EngelW. MECP2 mutations in sporadic cases of Rett syndrome are almost exlusively of paternal origin. J. Hum. Gen. 2001; 68, 5: 1093-1101.
    Publication of the article «World of Medicine and Biology» №4(62), 2017 year, 183-186 pages, index UDK 575.224:616-056.7-039.42
    DOI 10.26724/2079-8334-2017-4-62-183-186